Global Pain Management Drugs Market 2014-2018 -





TechNavio’s analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Pain Management Drugs market has also been witnessing intense competition among vendors. However, the increase in generic competition could pose a challenge to the growth of this market.

 
TechNavio’s report, the Global Pain Management Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pain Management Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

 
The key vendors dominating this space are Abbott Laboratories, Eli Lilly and Co., Endo Health Solutions Inc., Pfizer Inc., and Purdue Pharma L.P.

 
The other vendors mentioned in the report are Actavis plc, Allergen Inc., Astra Zenca plc, Baxter International Inc., Bayer Healthcare AG, Boehringer Ingelheim GmbH, Boston Scientific Corp., Bristol Myers Squibb Co., Durect Corp., F. Hoffmann La Roche Ltd., Forest Laboratories Inc., GlaxoSmithKline plc, Hospira Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pain Therapeutics Inc., Sanofi S.A., St. Jude Medical Inc., UCB S.A., Valeant Pharmaceuticals International Inc., and Zalicus Inc.

 
Key questions answered in this report:

 
What will the market size be in 2018 and what will be the growth rate?

 
What are the key market trends?

 
What is driving this market?

 
What are the challenges to market growth?

 
Who are the key vendors in this market space?

 
What are the market opportunities and threats faced by the key vendors?

 
What are the strengths and weaknesses of each of these key vendors?

 **Fiver User License Available for $2800.00. 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Category

07.1 Global Burn Pain Market

07.1.1 Market Size and Forecast

07.2 Global Cancer Pain Market

07.2.1 Market Size and Forecast

07.3 Global Dental/Facial Pain Market

07.3.1 Market Size and Forecast

07.4 Global Migraine Pain Market

07.4.1 Market Size and Forecast

07.5 Global Musculoskeletal Pain Market

07.5.1 Market Size and Forecast

07.6 Global Neuropathic Pain Market

07.6.1 Market Size and Forecast

07.7 Global Obstetrical Pain Market

07.7.1 Market Size and Forecast

07.8 Global Pediatric Pain Market

07.8.1 Market Size and Forecast

07.9 Global Surgical and Trauma Pain Market

07.9.1 Market Size and Forecast

08. Geographical Segmentation

08.1 Pain Management Drugs Market in the Americas

08.1.1 Market Size and Forecast

08.2 Pain Management Drugs Market in the EMEA Region

08.2.1 Market Size and Forecast

08.3 Pain Management Drugs Market in the APAC Region

08.3.1 Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Market Share Analysis 2013

16.3 Other Prominent Vendors

17. Key Vendor Analysis

17.1 Abbott Laboratories

17.1.1 Business Overview

17.1.2 Business Segmentation

17.1.3 Key Information

17.1.4 SWOT Analysis

17.2 Eli Lilly & Co.

17.2.1 Business Overview

17.2.2 Business Segmentation

17.2.3 Key Information

17.2.4 SWOT Analysis

17.3 Pfizer Inc.

17.3.1 Business Overview

17.3.2 Key Information

17.3.3 SWOT Analysis

17.4 Endo Health Solutions Inc.

17.4.1 Business Overview

17.4.2 Business Segmentation

17.4.3 Key Information

17.4.4 SWOT Analysis

17.5 Purdue Pharma L.P.

17.5.1 Business Overview

17.5.2 Key Information

17.5.3 SWOT Analysis

18. Other Reports in this Series


 
List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Pain Management Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Pain Management Market Segmentation by Category
Exhibit 4: Global Pain Management Drugs Market Segmentation 2013
Exhibit 5: Global Pain Management Drugs Market by Segments 2013-2018 (US$ million)
Exhibit 6: Global  Burn Pain Market 2013-2018 (US$ billion)
Exhibit 7: Global Cancer Pain Market 2013-2018 (US$ billion)
Exhibit 8: Global Dental/Facial Pain Market 2013-2018 (US$ billion)
Exhibit 9: Global Migraine Pain Market 2013-2018 (US$ billion)
Exhibit 10: Global Musculoskeletal Pain Market 2013-2018 (US$ billion)
Exhibit 11: Global Neuropathic Pain Market 2013-218 (US$ billion)
Exhibit 12: Global Obstetrical Pain Market 2013-2018 (US$ billion)
Exhibit 13: Global Pediatric Pain Market 2013-2018 (US$ billion)
Exhibit 14: Global Surgical and Trauma Pain Market 2013-2018 (US$ billion)
Exhibit 15: Global Pain Management Drugs Market By Product Segments (in terms of revenue)
Exhibit 16: Global Pain Management Drugs Market by Product Segments (percentage)
Exhibit 17: Global Pain Management Drugs Market by Geographical Segmentation 2013
Exhibit 18: Growth Pain Management Drugs by Geography 2013-2018 (US$ million)
Exhibit 19: Global Pain Management Drugs Market by Geography 2013-2018 (Percentage)
Exhibit 20: Pain Management Drugs Market in the Americas 2013-2018 (US$ billion)
Exhibit 21: Pain Management Drugs Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 22: Pain Management Drugs Market in the APAC Region 2013-2018 (US$ billion)
Exhibit 23: Global Pain Management Drugs Market by Geographical Segmentation (in terms of revenue)
Exhibit 24: Global Pain Management Drugs Market by Geographical Segmentation
Exhibit 25: Global Pain Management Drugs Market by Vendor Segmentation 2013
Exhibit 26: Business Segmentation of Abbott Laboratories
Exhibit 27: Business Segmentation of Eli Lilly & Co.
Exhibit 28: Business Segmentation of Endo Health Solutions Inc.